论文部分内容阅读
目的:观察清开灵注射液与利巴韦林注射液治疗上呼吸道感染的不同的临床疗效。方法:将我院门诊收治的120例确诊急性上呼吸道感染患者,分为治疗组和对照组,治疗组将清开灵注射液0.8ml/(kg.d)加入5%葡萄糖注射液250ml静滴,1次/d,3~5d为1个疗程;对照组将利巴韦林10~15mg/(kg.d)加入5%葡萄糖注射液250ml静滴,1次/d,3~5d为1个疗程,比较两组疗效。结果:两组比较,治疗组的临床疗效、症状好转时间、总有效率均明显优于对照组,差异均有显著性(P<0.01)。结论:清开灵注射液治疗急性上呼吸道感染,疗效显著,优于利巴韦林注射液,未发生不良反应。
Objective: To observe the different clinical effects of Qingkailing injection and ribavirin injection in the treatment of upper respiratory tract infection. Methods: One hundred and twenty cases of acute upper respiratory tract infection diagnosed in our hospital were divided into treatment group and control group. In the treatment group, Qingkailing injection 0.8ml / (kg · d) was added to 250ml intravenous infusion of 5% glucose injection , 1 / d, 3 ~ 5d for a course of treatment; control group ribavirin 10 ~ 15mg / (kg.d) added 5% glucose injection 250ml intravenous infusion, 1 times / d, 3 ~ 5d as 1 A course of treatment, the two groups were compared. Results: Compared with the control group, the clinical curative effect, the time of symptom improvement and the total effective rate of the two groups were significantly different (P <0.01). Conclusion: Qingkailing injection in the treatment of acute upper respiratory tract infection has obvious curative effect, which is superior to ribavirin injection without any adverse reaction.